MONECO ADVISORS, LLC

Position in DNLI — Denali Therapeutics Inc.

CIK 1765690 FAIRFIELD, CT

Position in DNLI

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$212,910

+$31,730 QoQ

Shares Held

8,278

-33.7% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#195

of 290 holders

Holding Since

Jun 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MONECO ADVISORS, LLC holds $2,660,345 across 4 Biotechnology names. DNLI ranks #4 (8.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	7,472	$1,828,921
2	EXEL	Exelixis, Inc.	6,155	$334,893
3	JAZZ	Jazz Pharmaceuticals plc	1,177	$283,621
4	DNLI	Denali Therapeutics Inc. This page	8,278	$212,910

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$212,910	8,278	-33.7%	Shares	Sole	2026-08-11
2025-09-30	$181,180	12,478	+19.1%	Shares	Sole	2025-11-05
2025-06-30	$146,587	10,478	-1.2%	Shares	Sole	2025-08-13
2025-03-31	$144,107	10,600	0.0%	Shares	Sole	2025-08-15
2024-12-31	$216,028	10,600	+16.5%	Shares	Sole	2025-08-15
2024-09-30	$265,083	9,100	+4.6%	Shares	Sole	2024-10-25
2024-06-30	$202,014	8,700	—	Shares	Sole	2024-07-19
No filing history on record for this holder in this stock.